Expertise in
12
conditions

Maryvonne Hourmant

Nantes, FR 
Expertise in
12
conditions
Nantes, FR 

Overview

Maryvonne Hourmant practices practicing medicine in Nantes, France.

Hourmant is highly rated in 12 conditions, according to our data. Their clinical expertise encompasses Atypical Hemolytic Uremic Syndrome (aHUS), Hemolytic-Uremic Syndrome, D-Minus Hemolytic Uremic Syndrome, Kidney Transplant, and Pancreas Transplant.

They are actively involved in clinical research, co-authoring 90 peer reviewed articles and participating in 2 clinical trials.

Locations

Nantes, France
Other Locations
Dijon, France
Strasbourg, France
France, France
CHU de Tours
Tours, France
Brest, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
Impact of Therapeutic Hypothermia in Expanded Criteria Brain-dead Donors on Kidney-graft Function in the Kidney-transplant Recipients: Multicenter Randomized Controlled Trial HYPOREME
Impact of Therapeutic Hypothermia in Expanded Criteria Brain-dead Donors on Kidney-graft Function in the Kidney-transplant Recipients: Multicenter Randomized Controlled Trial HYPOREME
Enrollment Status: Completed
Publish Date: June 21, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

90 Total Publications

Greener care, smarter spending: economic opportunities in sustainable nephrology.
Greener care, smarter spending: economic opportunities in sustainable nephrology.
Journal: Clinical kidney journal
Published: January 28, 2026

Frequently Asked Questions about Maryvonne Hourmant

Is Maryvonne Hourmant a top-rated expert for Atypical Hemolytic Uremic Syndrome (aHUS)?

MediFind is an objective health platform that identifies experts based on real-world data. Maryvonne Hourmant is classified as an Elite expert for Atypical Hemolytic Uremic Syndrome (aHUS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Maryvonne Hourmant participate in research or clinical trials?

Yes. Maryvonne Hourmant has published 90 articles and abstracts on conditions like Atypical Hemolytic Uremic Syndrome (aHUS). You can view a list of Maryvonne Hourmant's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hourmant's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile